Influence of DNA repair gene polymorphisms on prognosis in inoperable non-small cell lung cancer patients treated with radiotherapy and platinum-based chemotherapy

International Journal of Cancer

Volumn 131, Issue 7, 2012, Pages

  Butkiewicz, Dorota ^a   Drosik, Anna ^a   Suwiński, Rafał ^a   Krześniak, Małgorzata ^a   Rusin, Marek ^a   Kosarewicz, Agata ^a   Rachtan, Jadwiga ^b   Matuszczyk, Iwona ^a   Gawkowska Suwińska, Marzena ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

^b INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

DNA repair; lung cancer; polymorphism; survival; XPA

Indexed keywords

ANTINEOPLASTIC AGENT; PLATINUM COMPLEX;

ADULT; AGED; ALLELE; ARTICLE; CANCER GROWTH; CANCER MORTALITY; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CHEMORADIOTHERAPY; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; DNA REPAIR; DNA REPAIR GENE; FEMALE; GENE; GENOTYPE; HETEROZYGOTE; HOGG1 GENE; HUMAN; HUMAN TISSUE; INOPERABLE CANCER; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; XPA GENE; XPD GENE; XRCC1 GENE; XRCC2 GENE; XRCC3 GENE;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; DNA REPAIR; FEMALE; GENOTYPE; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROGNOSIS;

EID: 84864495074     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27596     Document Type: Article

References (43)

1. Wojciechowska U, Didkowska J, Zatoński W, Cancer in Poland in 2008. Warszawa: The M. Skłodowska-Curie Memorial Cancer Center and Institute of Oncology, 2010.
2. Rabik CA, Dolan ME,. Molecular mechanisms of resistance and toxicity associated with platinating agents. Cancer Treat Rev 2007; 33: 9-23.
3. Guo WF, Lin RX, Huang J, et al. Identification of differentially expressed genes contributing to radioresistance in lung cancer cells using microarray analysis. Radiat Res 2005; 164: 27-35.
4. Hoeijmakers JH,. Genome maintenance mechanisms for preventing cancer. Nature 2001; 411: 366-374.
5. Zienolddiny S, Campa D, Lind H, et al. Polymorphisms of DNA repair genes and risk of non-small cell lung cancer. Carcinogenesis 2006; 27: 560-567.
6. Kiyohara C, Takayama K, Nakanishi Y,. Lung cancer risk and genetic polymorphisms in DNA repair pathways: a meta-analysis. J Nucleic Acids 2010; 2010: 701760.
7. Parliament MB, Murray D,. Single nucleotide polymorphisms of DNA repair genes as predictors of radioresponse. Semin Radiat Oncol 2010; 20: 232-240.
8. Wood RD,. Nucleotide excision repair in mammalian cells. J Biol Chem 1997; 272: 23465-23468.
9. Robertson AB, Klungland A, Rognes T, et al. DNA repair in mammalian cells: Base excision repair: the long and short of it. Cell Mol Life Sci 2009; 66: 981-993.
10. Spitz MR, Wu X, Wang Y, et al. Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients. Cancer Res 2001; 61: 1354-1357.
11. Wu X, Zhao H, Wei Q, et al. XPA polymorphism associated with reduced lung cancer risk and a modulating effect on nucleotide excision repair capacity. Carcinogenesis 2003; 24: 505-509.
12. Zhan P, Wang Q, Wei SZ, et al. ERCC2/XPD Lys751Gln and Asp312Asn gene polymorphism and lung cancer risk: a meta-analysis involving 22 case-control studies. J Thorac Oncol 2010; 5: 1337-1345.
13. Aka P, Mateuca R, Buchet JP, et al. Are genetic polymorphisms in OGG1, XRCC1 and XRCC3 genes predictive for the DNA strand break repair phenotype and genotoxicity in workers exposed to low dose ionising radiations? Mutat Res 2004; 556: 169-181.
14. Janik J, Swoboda M, Janowska B, et al. 8-Oxoguanine incision activity is impaired in lung tissues of NSCLC patients with the polymorphism of OGG1 and XRCC1 genes. Mutat Res 2011; 709-710: 21-31.
15. Mangoni M, Bisanzi S, Carozzi F, et al. Association between genetic polymorphisms in the XRCC1, XRCC3, XPD, GSTM1, GSTT1, MSH2, MLH1, MSH3, and MGMT genes and radiosensitivity in breast cancer patients. Int J Radiat Oncol Biol Phys 2011; 81: 52-58.
16. Wu X, Lu C, Ye Y, et al. Germline genetic variations in drug action pathways predict clinical outcomes in advanced lung cancer treated with platinum-based chemotherapy. Pharmacogenet Genomics 2008; 18: 955-965.
17. Yin M, Liao Z, Huang YJ, et al. Polymorphisms of homologous recombination genes and clinical outcomes of non-small cell lung cancer patients treated with definitive radiotherapy. PLoS One 2011; 6: e20055.
18. Butkiewicz D, Rusin M, Sikora B, et al. An association between DNA repair gene polymorphisms and survival in patients with resected non-small cell lung cancer. Mol Biol Rep 2011; 38: 5231-5241.
19. Zhang Y, Rohde LH, Wu H,. Involvement of nucleotide excision and mismatch repair mechanisms in double strand break repair. Curr Genomics 2009; 10: 250-258.
20. Kozak M,. Interpreting cDNA sequences: some insights from studies on translation. Mamm Genome 1996; 7: 563-574.
21. Butkiewicz D, Krześniak M, Vaitiekunaite R, et al. A functional analysis of G23A polymorphism and the alternative splicing in the expression of the XPA gene. Cell Mol Biol Lett 2010; 15: 611-629.
22. Pavanello S, Pulliero A, Siwinska E, et al. Reduced nucleotide excision repair and GSTM1-null genotypes influence anti-B[a]PDE-DNA adduct levels in mononuclear white blood cells of highly PAH-exposed coke oven workers. Carcinogenesis 2005; 26: 169-175.
23. Dusinska M, Dzupinkova Z, Wsolova L, et al. Possible involvement of XPA in repair of oxidative DNA damage deduced from analysis of damage, repair and genotype in a human population study. Mutagenesis 2006; 21: 205-211.
24. Langie SA, Wilms LC, Hämäläinen S, et al. Modulation of nucleotide excision repair in human lymphocytes by genetic and dietary factors. Br J Nutr 2010; 103: 490-501.
25. Feng J, Sun X, Sun N, et al. XPA A23G polymorphism is associated with the elevated response to platinum-based chemotherapy in advanced non-small cell lung cancer. Acta Biochim Biophys Sin (Shanghai) 2009; 41: 429-435.
26. Gu J, Zhao H, Dinney CP, et al. Nucleotide excision repair gene polymorphisms and recurrence after treatment for superficial bladder cancer. Clin Cancer Res 2005; 11: 1408-1415.
27. Wu X, Gu J, Wu TT, et al. Genetic variations in radiation and chemotherapy drug action pathways predict clinical outcomes in esophageal cancer. J Clin Oncol 2006; 24: 3789-3798.
28. Carles J, Monzo M, Amat M, et al. Single-nucleotide polymorphisms in base excision repair, nucleotide excision repair, and double strand break genes as markers for response to radiotherapy in patients with Stage I to II head-and-neck cancer. Int J Radiat Oncol Biol Phys 2006; 66: 1022-1030.
29. Camenisch U, Nägeli H,. XPA gene, its product and biological roles. Adv Exp Med Biol 2008; 637: 28-38.
30. Cleaver JE, States JC,. The DNA damage-recognition problem in human and other eukaryotic cells: the XPA damage binding protein. Biochem J 1997; 328: 1-12.
31. Köberle B, Masters JR, Hartley JA, et al. Defective repair of cisplatin-induced DNA damage caused by reduced XPA protein in testicular germ cell tumours. Curr Biol 1999; 9: 273-276.
32. Yang Z, Roginskaya M, Colis LC, et al. Specific and efficient binding of xeroderma pigmentosum complementation group A to double-strand/single-strand DNA junctions with 3'- and/or 5'-ssDNA branches. Biochemistry 2006; 45: 15921-15930.
33. Zhang Y, Rohde LH, Emami K, et al. Suppressed expression of non-DSB repair genes inhibits gamma-radiation-induced cytogenetic repair and cell cycle arrest. DNA Repair(Amst) 2008; 7: 1835-1845.
34. Monaco R, Rosal R, Dolan MA, et al. Conformational effects of a common codon 399 polymorphism on the BRCT1 domain of the XRCC1 protein. Protein J 2007; 26: 541-546.
35. Cheng J, Leng S, Li H, et al. Suboptimal DNA repair capacity predisposes coke-oven workers to accumulate more chromosomal damages in peripheral lymphocytes. Cancer Epidemiol Biomarkers Prev 2009; 18: 987-993.
36. Au WW, Salama SA, Sierra-Torres CH,. Functional characterization of polymorphisms in DNA repair genes using cytogenetic challenge assays. Environ Health Perspect 2003; 111: 1843-1850.
37. Qiao Y, Spitz MR, Guo Z, et al. Rapid assessment of repair of ultraviolet DNA damage with a modified host-cell reactivation assay using a luciferase reporter gene and correlation with polymorphisms of DNA repair genes in normal human lymphocytes. Mutat Res 2002; 509: 165-174.
38. Hung RJ, Christiani DC, Risch A, et al. International Lung Cancer Consortium: pooled analysis of sequence variants in DNA repair and cell cycle pathways. Cancer Epidemiol Biomarkers Prev 2008; 17: 3081-3089.
39. Yoon SM, Hong YC, Park HJ, et al. The polymorphism and haplotypes of XRCC1 and survival of non-small-cell lung cancer after radiotherapy. Int J Radiat Oncol Biol Phys 2005; 63: 885-891.
40. Kalikaki A, Kanaki M, Vassalou H, et al. DNA repair gene polymorphisms predict favorable clinical outcome in advanced non-small-cell lung cancer. Clin Lung Cancer 2009; 10: 118-123.
41. Gurubhagavatula S, Liu G, Park S, et al. XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy. J Clin Oncol 2004; 22: 2594-2601.
42. Yin Z, Zhou B, He Q, et al. Association between polymorphisms in DNA repair genes and survival of non-smoking female patients with lung adenocarcinoma. BMC Cancer 2009; 9: 439.
43. Yin M, Liao Z, Liu Z, et al. Functional polymorphisms of base excision repair genes XRCC1 and APEX1 predict risk of radiation pneumonitis in patients with non-small cell lung cancer treated with definitive radiation therapy. Int J Radiat Oncol Biol Phys 2011; 81: e67-e73.